Certara Services Archives

Guide

Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer

Download Certara’s expert guide on pharmacometrics and pediatric drug development. Learn how modeling, MIDD, and…

CertaraMarch 19, 2026

Press Coverage Video

Rethinking Trial Design With Bayesian Approaches

Learn how Bayesian approaches are transforming clinical trial design by enabling adaptive studies, data borrowing,…

CertaraMarch 19, 2026

Blog Knowledge Base

What is GLP (Good Laboratory Practice)?

Read this blog to understand GLP (Good Laboratory Practice) and associated QA audits, and proper…

CertaraMarch 18, 2026

Blog

Why You Should Participate in the Voluntary FDA Oncology Center of Excellence Assessment Aid Program

Learn how the FDA assessment aid streamlines oncology NDA/BLA reviews, what to include, and best…

CertaraMarch 17, 2026

Press Coverage Video

FDA Support Drives Shift Toward Bayesian Trial Design

Explore how Bayesian statistical methods are reshaping clinical trial design. Learn how FDA support, adaptive…

Danielle PillsburyMarch 13, 2026

Press Coverage

Single Pivotal Trials Demand Stronger Data and Risk Strategies

As regulators increasingly accept single pivotal trials for drug approval, sponsors must strengthen data quality,…

CertaraMarch 13, 2026

Blog

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Explore how model-informed drug development and AI are advancing pharmacoequity and shaping the future of…

CertaraMarch 11, 2026

Press Coverage Video

Advancing Bayesian Methods in Clinical Trials

Explore how Bayesian statistical methods are reshaping clinical trial design. Learn how FDA support, adaptive…

CertaraMarch 9, 2026

Blog

Pharmacovigilance Aggregate Reporting in China

Learn best practices for China pharmacovigilance aggregate reporting, with expert support and regulatory guidance insights.

CertaraMarch 6, 2026

Blog

DIA RSIDM 2026: From Doing Digital to Being Data-Driven

JTVCdGVhbV9qdW1wX2xpc3QlNUQ= March 5, 2026 The atmosphere at this year's DIA RSIDM conference was defined by…

CertaraMarch 5, 2026

Certara Services

Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer

Rethinking Trial Design With Bayesian Approaches

What is GLP (Good Laboratory Practice)?

Why You Should Participate in the Voluntary FDA Oncology Center of Excellence Assessment Aid Program

FDA Support Drives Shift Toward Bayesian Trial Design

Single Pivotal Trials Demand Stronger Data and Risk Strategies

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Advancing Bayesian Methods in Clinical Trials

Pharmacovigilance Aggregate Reporting in China

DIA RSIDM 2026: From Doing Digital to Being Data-Driven

Newsletter sign up

Quick links

Solutions

Contact